reported a 49.2% fall in quarterly profit, missing analysts' estimates, as the generic drug maker grappled with pricing pressures in key markets like the United States.
The Hyderabad-based company's core business is manufacturing of active pharmaceutical ingredients , which are chemical compounds in a drug that help produce desired health effects.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: